Filing Details
- Accession Number:
- 0001225208-17-016030
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-10-05 16:16:07
- Reporting Period:
- 2017-10-03
- Accepted Time:
- 2017-10-05 16:16:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885725 | Boston Scientific Corp | BSX | Surgical & Medical Instruments & Apparatus (3841) | 042695240 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1538431 | Supratim Bose | 300 Boston Scientific Way Marlborough MA 01752-1234 | Evp & President, Asia-Pacific | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-10-03 | 174,672 | $5.36 | 494,973 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-10-03 | 22,145 | $6.28 | 517,118 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-10-03 | 196,817 | $29.08 | 320,301 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-10-04 | 88,071 | $7.39 | 408,372 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-10-04 | 23,907 | $13.08 | 432,279 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-10-04 | 15,352 | $6.28 | 447,631 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-10-04 | 15,086 | $16.31 | 462,717 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-10-04 | 7,904 | $17.26 | 470,621 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-10-04 | 150,320 | $29.18 | 320,301 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-10-03 | 174,672 | $0.00 | 174,672 | $5.36 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-10-03 | 22,145 | $0.00 | 22,145 | $6.28 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-10-04 | 7,904 | $0.00 | 7,904 | $17.26 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-10-04 | 15,086 | $0.00 | 15,086 | $16.31 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-10-04 | 23,907 | $0.00 | 23,907 | $13.08 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-10-04 | 15,352 | $0.00 | 15,352 | $6.28 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-10-04 | 88,071 | $0.00 | 88,071 | $7.39 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-01-03 | No | 4 | M | Direct | |
| 15,352 | 2022-02-27 | No | 4 | M | Direct | |
| 23,714 | 2026-02-22 | No | 4 | M | Direct | |
| 15,086 | 2025-02-23 | No | 4 | M | Direct | |
| 7,969 | 2024-02-24 | No | 4 | M | Direct | |
| 0 | 2022-02-27 | No | 4 | M | Direct | |
| 0 | 2023-02-28 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
- Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.4901, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.07 to $29.255, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on January 3, 2013, the first anniversary of the grant.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.
Billionaire Hedge Funds
